Physicians have until Sept. 8 to review information regarding items of value received from medical drug, device and supply manufacturers and to register disputes before that information is made available to the public.
The Sunshine Act, a component of the Affordable Care Act, requires manufacturers of drugs, medical devices, biologicals and medical supplies to report to the Center for Medicare and Medicaid Services (CMS) payments or other transfers of value made to physicians and teaching hospitals. Applicable manufacturers and group purchasing organizations (GPOs) also must disclose physician ownership or investment interests.
Manufacturers and GPOs were required to submit data to CMS covering the time period between Aug. 1 and Dec. 31, 2013. That data will be made publicly available by Sept. 30, 2014, but physicians can review and initiate disputes regarding their data until Sept. 8. Data that is disputed by a physician on or before Sept. 8 will be designated as disputed when the data is released to the public. Disputes regarding 2013 data can be initiated until Dec. 31, 2014, but disputes initiated after Sept. 8 will not be reflected in the public database until 2015.
To review the data, physicians must first register with the CMS Enterprise Portal here and then register with the CMS Open Payments system. Information about how to register with the Open Payments system is available here. Guidelines on how to review and dispute information is available here. To access the CMS webpage with information and resources about the Open Payments system that are specific to physicians, click here.
WMJ has published two articles regarding the Sunshine Act and what it means for physicians. The first article addresses inclusion in the reporting database and the second article focuses on what and how to report. The final Sunshine Act rule is available here. The AMA also has developed a Toolkit for Physician Financial Transparency Reporting, which is available here.
Back to August 28, 2014 Medigram